Kim Hanjoon Alex (CIK 1919209) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-22). Recent activity: Sell LAB (18,871 shares), Buy LAB (323,173 shares), Buy LAB (70,183 shares), Sell LAB (21,301 shares), Sell LAB (12,740 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-22 | STANDARD BIOTOOLS INC. (LAB) | Chief Financial Officer | Sell | 18,871 | $18,871 |
| 2026-04-08 | STANDARD BIOTOOLS INC. (LAB) | Chief Financial Officer | Buy | 323,173 | $0 |
| 2026-04-08 | STANDARD BIOTOOLS INC. (LAB) | Chief Financial Officer | Buy | 70,183 | $0 |
| 2026-04-08 | STANDARD BIOTOOLS INC. (LAB) | Chief Financial Officer | Sell | 21,301 | $19,341 |
| 2026-02-24 | STANDARD BIOTOOLS INC. (LAB) | Chief Financial Officer | Sell | 12,740 | $14,651 |
| 2025-11-24 | STANDARD BIOTOOLS INC. (LAB) | Chief Financial Officer | Sell | 12,739 | $16,306 |
| 2025-08-22 | STANDARD BIOTOOLS INC. (LAB) | Chief Financial Officer | Sell | 12,739 | $16,179 |
| 2025-08-05 | STANDARD BIOTOOLS INC. (LAB) | Chief Financial Officer | Buy | 1.5M | $0 |
| 2025-05-30 | STANDARD BIOTOOLS INC. (LAB) | Chief Financial Officer | Sell | 2,583 | $2,815 |
| 2025-05-28 | STANDARD BIOTOOLS INC. (LAB) | Chief Financial Officer | Sell | 1,428 | $1,342 |
| 2025-05-27 | STANDARD BIOTOOLS INC. (LAB) | Chief Financial Officer | Sell | 1,355 | $1,355 |
| 2025-05-22 | STANDARD BIOTOOLS INC. (LAB) | Chief Financial Officer | Sell | 6,364 | $6,682 |
| 2025-05-22 | STANDARD BIOTOOLS INC. (LAB) | Chief Financial Officer | Sell | 1,407 | $1,449 |
| 2025-04-08 | STANDARD BIOTOOLS INC. (LAB) | Chief Financial Officer | Buy | 70,183 | $0 |
| 2025-04-08 | STANDARD BIOTOOLS INC. (LAB) | Chief Financial Officer | Sell | 21,441 | $22,942 |
| 2025-03-24 | STANDARD BIOTOOLS INC. (LAB) | Chief Financial Officer | Buy | 338,333 | $0 |
Source: SEC Form 4 filings · as of 2026-05-22